Weitz JI - Search Results

1

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.

Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators. Raskob GE, et al. Among authors: weitz ji. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Free article. Clinical Trial.

2

Low-molecular-weight heparins.

Weitz JI. Weitz JI. N Engl J Med. 1997 Sep 4;337(10):688-98. doi: 10.1056/NEJM199709043371007. N Engl J Med. 1997. PMID: 9278467 Review. No abstract available.

3

Clinical utility of a rapid whole-blood D-dimer assay in patients with cancer who present with suspected acute deep venous thrombosis.

Lee AY, Julian JA, Levine MN, Weitz JI, Kearon C, Wells PS, Ginsberg JS. Lee AY, et al. Among authors: weitz ji. Ann Intern Med. 1999 Sep 21;131(6):417-23. doi: 10.7326/0003-4819-131-6-199909210-00004. Ann Intern Med. 1999. PMID: 10498557

4

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.

Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Eikelboom JW, et al. Among authors: weitz ji. Lancet. 2000 Jun 3;355(9219):1936-42. doi: 10.1016/S0140-6736(00)02324-2. Lancet. 2000. PMID: 10859038

5

Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.

Brill-Edwards P, Ginsberg JS, Gent M, Hirsh J, Burrows R, Kearon C, Geerts W, Kovacs M, Weitz JI, Robinson KS, Whittom R, Couture G; Recurrence of Clot in This Pregnancy Study Group. Brill-Edwards P, et al. Among authors: weitz ji. N Engl J Med. 2000 Nov 16;343(20):1439-44. doi: 10.1056/NEJM200011163432002. N Engl J Med. 2000. PMID: 11078768 Free article. Clinical Trial.

6

Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2)study.

Eikelboom JW, Anand SS, Mehta SR, Weitz JI, Yi C, Yusuf S. Eikelboom JW, et al. Among authors: weitz ji. Circulation. 2001 Feb 6;103(5):643-50. doi: 10.1161/01.cir.103.5.643. Circulation. 2001. PMID: 11156874 Clinical Trial.

7

Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.

Crowther MA, Roberts J, Roberts R, Johnston M, Stevens P, Skingley P, Patrassi GM, Sartori MT, Hirsh J, Prandoni P, Weitz JI, Gent M, Ginsberg JS. Crowther MA, et al. Among authors: weitz ji. Thromb Haemost. 2001 Mar;85(3):390-4. Thromb Haemost. 2001. PMID: 11307802 Clinical Trial.

8

Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.

Lee AY, Fredenburgh JC, Stewart RJ, Rischke JA, Weitz JI. Lee AY, et al. Among authors: weitz ji. Thromb Haemost. 2001 Mar;85(3):502-8. Thromb Haemost. 2001. PMID: 11307822

9

Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing.

Kearon C, Ginsberg JS, Douketis J, Crowther M, Brill-Edwards P, Weitz JI, Hirsh J. Kearon C, et al. Among authors: weitz ji. Ann Intern Med. 2001 Jul 17;135(2):108-11. doi: 10.7326/0003-4819-135-2-200107170-00011. Ann Intern Med. 2001. PMID: 11453710

10

Direct thrombin inhibitors in acute coronary syndromes: present and future.

Weitz JI, Buller HR. Weitz JI, et al. Circulation. 2002 Feb 26;105(8):1004-11. doi: 10.1161/hc0802.104331. Circulation. 2002. PMID: 11864933 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

552 results

Search Page